Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
AHCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.11 - $11.90
Previous CloseN/A
Volume245.49K
Average Volume (3M)1.23M
Market Cap
$1.29B
Enterprise Value$4.86B
Total Cash (Recent Filing)$53.65M
Total Debt (Recent Filing)$2.10B
Price to Earnings (P/E)16.8
Beta1.03
Next Earnings
Aug 12, 2025EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding134,947,900
10 Day Avg. Volume1,941,049
30 Day Avg. Volume1,228,223
Financial Highlights & Ratios
PEG Ratio-0.69
Price to Book (P/B)1.20
Price to Sales (P/S)0.00
P/FCF Ratio-146.89
Enterprise Value/Market Cap3.77
Enterprise Value/Revenue0.38
Enterprise Value/Gross Profit10.21
Enterprise Value/Ebitda3.43
Forecast
1Y Price Target
$13.33Price Target Upside39.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
AdaptHealth News
PremiumCompany Announcements
AdaptHealth Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
AdaptHealth Reports Q1 2025 Financial Results
PremiumCompany Announcements
AdaptHealth’s Mixed Earnings Call Highlights Progress and Challenges
Bulls Say, Bears Say
Bulls Say
Diabetes Segment PerformanceDiabetes continues to show signs of early progress, exceeding internal targets for the quarter.
Free Cash FlowAHCO reported a strong free cash flow of $73 million in Q4, representing a 10% year-over-year growth.
Strategic DivestituresAHCO continues to deliver on initiatives to strategically divest ~$100m of annual revenues with non-core asset sales.
Bears Say
Revenue And EBITDA ForecastAHCO lowered its 2025 revenue outlook and EBITDA forecast, partially due to the new asset sale announcement.
Sales Force ChangesManagement rolled out quotas for its sales force, and there is caution as such moves could be disruptive or cause employee turnover and revenue volatility.
Sleep Segment ChallengesNew challenges in sleep entered the picture this quarter, with competitors gaining share in a few states.
Ownership Overview
3.49% Insiders
21.95% Mutual Funds
6.06% Other Institutional Investors
46.70% Public Companies and Individual Investors
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $7.11 and its highest was $11.90 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.29B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Aug 12, 2025 which is in 44 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on May 06, 2025. The company reported $0.027 earnings per share for the quarter, missing the consensus estimate of $0.047 by -$0.02.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.15.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 134,947,900 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.027 in its last earnings report, missing expectations of $0.047. Following the earnings report the stock price went up 1.724%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.33 (39.58% Upside)
$13.33 (39.58% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.14%
12-Months-Change
Fundamentals
Return on Equity
5.12%
Trailing 12-Months
Asset Growth
-1.47%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance, with notable achievements in debt reduction and improvements in the Respiratory and Diabetes Health segments. However, overall revenue and adjusted EBITDA declines, as well as challenges in the Sleep Health segment, balanced the positive aspects. The sentiment is neutral, reflecting both progress and ongoing challenges.Read More>AHCO Stock 12 Month Forecast
Average Price Target
$13.33
▲(39.58%Upside)
Technical Analysis
Ufp Technologies
―
LivaNova
―
Senseonics Holdings
―
Establishment Labs Holdings
―
Bioventus
―